Medical Devices Australia

Australia Hypertension Management Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia Hypertension Management Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $47.1 Mn Placeholder estimate
Estimate 2025 $51.6 Mn 1.3% of the global market
Projected 2034 $118.8 Mn 130.1% Adds $67.2 Mn over 9 forecast years
CAGR 2025–2034 9.7% Faster than 47% of 180 Medical Devices markets here
Key players 5
  • Australia is 1.26% of the global market.
  • In APAC, the largest is China at $376.7 Mn.
  • Fastest growing: India at 11.4% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$67.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hypertension Management Devices Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $47.1 Mn — —
2025 (base) $51.6 Mn +$4.6 Mn —
2026 (forecast) $56.6 Mn +$5.0 Mn +9.7%
2027 (forecast) $62.1 Mn +$5.5 Mn +20.3%
2028 (forecast) $68.2 Mn +$6.0 Mn +32%
2029 (forecast) $74.8 Mn +$6.6 Mn +44.8%
2030 (forecast) $82.0 Mn +$7.3 Mn +58.9%
2031 (forecast) $90.0 Mn +$8.0 Mn +74.3%
2032 (forecast) $98.7 Mn +$8.7 Mn +91.2%
2033 (forecast) $108.3 Mn +$9.6 Mn +109.7%
2034 (forecast) $118.8 Mn +$10.5 Mn +130.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Hypertension Management Devices Market Analysis at a glance
Market size, 2025$51.6 Mn placeholder estimate
Forecast, 2034$118.8 Mn placeholder estimate
Growth (CAGR), 2025–20349.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, channel and end user (see all)
Key playersOmron Healthcare, Withings, A&D Medical, Microlife, Medtronic (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Hypertension Management Devices Market Analysis Executive Summary

Hypertension management devices include home blood pressure monitors, connected cuffs and new procedures that help control high blood pressure.

Key segments of the hypertension Management Devices market include product (Home Blood Pressure Monitors, Connected Monitors and Ambulatory Monitors) and channel (Retail, Online and Clinics).

Bar chart: Australia Hypertension Management Devices market size, 2024–2034, placeholder estimates. $47.1 Mn in 2024, $51.6 Mn in 2025 and $118.8 Mn in 2034, 9.7% CAGR.
Australia Hypertension Management Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Hypertension Management Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the hypertension Management Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the hypertension Management Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the hypertension Management Devices market.

Competitive Landscape for Hypertension Management Devices Market in Australia

The hypertension Management Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hypertension Management Devices Market in Australia

Hypertension Management Devices in Australia: rules, payment and health figures

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2] High blood pressure (ages 30–79): 29.3% of adults 30–79 in 2019, the latest WHO figure for Australia.⁠[3]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 20 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hypertension Management Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hypertension Management Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hypertension Management Devices in context

Australia compared

  • High blood pressure (ages 30–79): 29.3% of adults 30–79 (2019). World: 33.1% of adults 30–79 (2019). 13th highest of the 17 countries we cover in APAC.[1]
  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in APAC.[2]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hypertension Management Devices market in Australia?
Placeholder estimate: about $51.6 Mn in 2025, rising to about $118.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hypertension Management Devices market in Australia growing?
Placeholder estimate: about 9.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hypertension Management Devices market report cover?
The report splits the market by product (Home Blood Pressure Monitors, Connected Monitors, Ambulatory Monitors, Renal Denervation), channel (Retail, Online, Clinics) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hypertension Management Devices market?
Key players include Omron Healthcare, Withings, A&D Medical, Microlife and Medtronic.
What is driving the Hypertension Management Devices market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the hypertension Management Devices market.
Who regulates Hypertension Management Devices in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
What does WHO report for Australia?
High blood pressure (ages 30–79): 29.3% of adults 30–79 in 2019, the latest WHO figure. Source: WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 20 Nov 2026.
How many people in Australia are 65 or older?
18.1% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 19 Nov 2026.
How much research is published on Hypertension Management Devices?
PubMed lists 158 papers on Hypertension Management Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on hypertension and remote monitoring and wearables

See the topic